Use of private providers, poor training and inadequate regulation mean obtaining care has become a ‘wild west’ ...

FoIs show integrated care boards saving money by curbing assessments have not informed GPs or patients facing long waits ...

GP practices are increasingly withdrawing from shared-care agreements with patients diagnosed by private clinics ...

Bowie reports on Sweden’s plans to introduce autism and attention deficit/hyperactivity disorder (ADHD) de-diagnosing ...

A think tank report reveals spending on ADHD services is estimated to reach £314m by April 2026 - more than double the annual ...

People with attention deficit hyperactivity disorder (ADHD) may have a “deeply concerning” reduced life expectancy compared to those without it, a UK study of over 30,000 individuals with diagnosed ...

A common character trait millions of people expertience every day could be a red flag sign of Attention Deficit Hyperactivity ...

The stimulants Ritalin and Adderall have been used to treat attention-deficit/hyperactivity disorder (ADHD) for decades, but ...

German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...